2021 IPO LIVE+Virtual Annual Meeting

/2021 IPO LIVE+Virtual Annual Meeting
2021 IPO LIVE+Virtual Annual Meeting 2021-07-22T10:58:46-04:00

Join IPO LIVE in Austin (Sept. 19-21)
or Virtual (Sept. 28-30)!

Questions: Contact IPO Meetings.


LIVE (In-person) Registration Fees
 (Sept. 19-21, Austin, TX):

  • IPO Member: $850 (Early Bird Discount of $100 by 8/31)
  • Non-member: $1,700 (Early Bird Discount of $200 by 8/31)
  • Government/Academic/Emeritus: $475 (Early Bird Discount of $100 by 8/31)

VIRTUAL Registration Fees (Sept. 28-30):

  • IPO Member: $400 (Early Bird Discount of $100 by 8/31)
  • Non-member: $800 (Early Bird Discount of $200 by 8/31)
  • Government/Academic/Emeritus: $250 (Early Bird Discount of $100 by 8/31)

Group Rate for IPO Members: $1,500

  • Rate includes unlimited virtual passes for all employees of the member organization + up to (2) in-person passes.
  • Additional fees will apply for each additional in-person pass beyond two.
  • To receive the group rate, an organization must submit a Group Form. IPO will then notify the organization once additional employees can register, for the virtual meeting, at no additional cost.

Join IPO for our LIVE+Virtual Annual Meeting! We look forward to providing an exceptional experience for our members that accommodates the broad array of health and safety comfort levels as well as travel policies and budgets. Registrants will be given the option to participate live or virtually. Both options offer access to the same educational content as well as unique networking opportunities. Click on the “Program” button for more information.

Keynote Speakers:

Hon. Alan Albright, Western District of Texas (Waco Division), will speak at the LIVE Annual Meeting on Sept. 20.
U.S. Senator Patrick Leahy (D-Vt.) will speak at the VIRTUAL Annual Meeting on Sept. 28.

As we confirm panels, we will indicate next to the title whether the session will be
LIVE + Virtual” or “Virtual Only.” Check back regularly for updates.


Sunday, September 19

12:00pm – 6:00pm CT –  IPO Registration Desk & Welcome Lounge. Attendees can check-in at the IPO Annual Meeting registration desk and pick up attendee materials, a welcome gift, and grab food and drinks in the welcome lounge. The welcome lounge offers a place to relax and network with other attendees.

6:00pm – 7:30pm CT – IPO Board of Directors & Speakers Dinner (by invitation only)

Evening (Times TBA) – Sponsor Receptions. More information will be posted soon! Open to all registered attendees.

Monday, September 20

7:00am CT – IPO Registration Desk Open. Breakfast is served in the IPOasis.
IPOasis sponsored by Leydig, Voit & Mayer, Ltd.

8:30am – 5:30pm CT – Education Sessions. Coffee Breaks and Lunch are served in the IPOasis.
IPOasis sponsored by Leydig, Voit & Mayer, Ltd.

11:00am – 1:00pm CT – IPO Board of Directors Meeting

Evening (Times TBA) – Sponsor Receptions. More information will be posted soon! Open to all registered attendees.

Tuesday, September 21

7:00am CT – IPO Registration Desk Open & Breakfast is served in the IPOasis.

8:30am – 5:00pm CT – Education Sessions. Coffee Breaks and Lunch are served in the IPOasis.


SESSION DESCRIPTIONS

General Sessions:

A Year in Review – Trends in IP Law and Recent Case Law (Patents, Trademarks, and Copyrights) (LIVE + Virtual)

2021 has been an active year for IP cases. The U.S. Supreme Court, the U.S. Court of Appeals for the Federal Circuit, and district courts have authored a number of opinions re-shaping and, in some cases, clarifying patent and trademark law. Speakers will provide key takeaways from these decisions and comment on cases to watch.

Hot Topics in Congress and at the PTO re. Diversity and Innovation in the IP Sphere (Virtual Only)
Organized by IPO’s Women in IP Law and US Patent Office Practice Committees

The Senate’s Subcommittee on Intellectual Property has had a very busy term, issuing requests for information and letters requesting USPTO action on (1) diversity in innovation metrics and processes at the USPTO and (2) increasing diversity within the patent bar. This session will summarize the key IP-related diversity topics that Congress and USPTO have advanced in the previous two years and will have a panel of practitioners discussing their progress and effect.

Implementing Advanced Analytics to Transform IP Department Operations (LIVE + Virtual)
Organized by IPO’s Corporate IP Management & Operations Committee

Advanced analytics are transforming the ways that all organizations are managed including within IP law firms and corporate legal departments. However, efforts to leverage these new tools often fail for a variety of reasons including internal resistance and the lack of a clear strategy for engaging existing analytics infrastructure which would aid in adoption within the organization (data scientists/people, processes, procedures). A “gold rush” currently exists across most organizations in efforts to harness data, leverage business intelligence tools and speed translation of these insights into even deeper analytics including machine learning, AI and other advanced models. IP organizations who excel in this arena must have the ability to effectively engage analytics infrastructure and new technology while also ensuring internal readiness across their team for adoption of these exciting new tools.

Storytelling for Leaders (LIVE + Virtual)
Organized by IPO’s Next Generation Leaders Committee

This session will offer tips on how to market yourself, personal branding, and how to convey the story you are trying to tell and advocate for an outcome.

Diversity and Innovation in the IP Sphere (LIVE + Virtual)
Organized by IPO’s Women in IP Law and US Patent Office Practice Committees

The Senate’s Subcommittee on Intellectual Property has had a very busy term, issuing requests for information and letters requesting USPTO action on (1) diversity in innovation metrics and processes at the USPTO and (2) increasing diversity within the patent bar. Panelists will discuss best practices and share examples from within their organizations.

Mental Health Challenges in the Legal Profession (LIVE + Virtual)

The legal profession is a high-pressure industry with long hours and tight deadlines. It is no wonder that lawyer well-being is an ever-present issue. That makes it vital that lawyers, companies, and law firms recognize the issue, provide education and training, and offer access to resources. This session will provide an overview of mental health issues that lawyers may be facing and how to identify signs that you or someone you know may be struggling. The panel will also provide resources and recommendations for ways to combat the many mental health challenges lawyers face today.

Management Tools to Help Improve Operational Efficiency (LIVE + Virtual)

Improving operational efficiency isn’t an easy task. But work done more efficiently decreases unnecessary company expenses, boosts revenue and most importantly, saves wasted time making the work more interesting. While many question the applicability of management tools like Six Sigma, Lean and Agile to legal work and can get turned off by the lingo, this session will demystify these tools and provide practical examples of how they can provide important organization learnings that lead to practical improvements.

Patent Sessions:

Compulsory Licensing and Related Issues – A Global Perspective (Virtual Only)
Organized by IPO’s International Patent Law and Trade, Asian Practice, European Practice, and Latin American Practice Committees

The session will explore proposed and existing compulsory licensing measures as well as compulsory licensing applications around the world with focus on North America, Europe, Latin America and Asia. Speakers will also address inter alia, IPO’s compulsory licensing board resolution, compulsory licensing as a global issue in the context of the proposed TRIPS waiver, whether compulsory licensing thwarts or promotes innovation and to what extent is compulsory licensing being used within certain countries to counteract a purported imbalance of essential patents within an industry, as a routine matter of public or industrial policy, and as a tool to facilitate access to innovative products and/or as a price negotiation tool.

Discretionary Denials of IPR Petitions by the PTAB: Recent Developments, Trends, and Effective Strategies (LIVE + Virtual)
Organized by IPO’s US Post-Grant Patent Office Practice and Patent Litigation Committees

This session will explore what have proven thus far to be effective strategies by patent owners and petitioners, including the choice of forum for the district court action by patent owners, and successful strategies that have been used by petitioners to avoid discretionary denials. Many stakeholders have criticized discretionary denials under the NHK/Fintiv criteria as too dependent on the district court in which the parallel case was filed. A substantial majority of IPR petitions in which the PTAB has denied institution based on those criteria have been related to cases pending in the Eastern District or Western District of Texas, where judges have set aggressive case management schedules with early trial dates. In comparison, very few PTAB discretionary denials relate to cases filed in the District of Delaware or the District of New Jersey. This panel will explore the substantive arguments made by the parties in the Apple v. Iancu case, as well as any decision and/or the issues on appeal of any such decision. The panel will also debate whether the NHK/Fintiv criteria are fair and equitable and whether they meet the goals of the AIA to have efficient and predictable determinations of whether patents are invalid. The panel will also discuss alternative criteria that might be considered by the USPTO.

Data Issues and Best Practices Related to Artificial Intelligence Agreements (LIVE + Virtual)
Organized by IPO’s AI & Other Emerging Technologies and IP Licensing & Related Issues Committees

The digital transformation, which has been accelerated due to the global pandemic, is largely fueled by increasingly rich data being generated by software and advanced sensors.  Artificial intelligence including machine learning and analytics are crucial in making large data sets valuable and actionable.  However, success of these techniques is high-quality, descriptive data that often requires thoughtful curation to avoid falling into a “garbage in, garbage out” solution. Companies are increasingly recognizing the value of their data and, as such, careful considerations need to be taken when entering into partnering agreements. For example, ownership of training data, validation data, model improvements and the like need to be specifically defined and negotiated and this panel will discuss best practices regarding same.

Where to Sue When Your Trade Secret Is Misappropriated Outside the U.S (Virtual Only)
Organized by IPO’s Trade Secrets, Asian Practice, and US International Trade Commission Committees

Our economy is undeniably globalized. In many situations, US companies must expose their trade secrets to partners or others outside the US who could misuse the trade secrets. In some cases, actors outside the US reach directly or indirectly into the US and misappropriate trade secrets. If your trade secret is misappropriated, one of your most important decisions is choosing where to sue. This panel will discuss considerations relevant to choosing where to bring a suit if some or all of the conduct occurred outside the US. Speakers will contrast and compare these options:  (1) a court outside the US, with particular focus on China; (2) the US International Trade Commission (ITC); (3) a US District Court or US state court; and (4) some combination of the above. The panel will also discuss the advantages and drawbacks of bringing a trade secret case in the ITC, which has been increasing the number of trade secrets investigations that it conducts.

Duty of Disclosure & Inequitable Conduct (LIVE + Virtual)
Organized by IPO’s US Patent Law Committee

Post-Therasense, Patent law is left with a number of conflicting and, in some cases, impractical standards for Duty of Candor (including Duty of Disclosure) that can be confusing for both the patent owner and practitioner to navigate. With regard to the duty of disclosure, there is some question as to whether it brings enough benefit to the Examiner’s search to warrant the high operational costs of compliance, especially taking into account the experiences of other jurisdictions that lack this requirement. This session will detail some possible rule-making and legislative approaches to addressing these issues.

Global Rate-Setting for Standards-Essential Patents (LIVE + Virtual)
Organized by IPO’s Damages & Injunctions, Standards Setting, and International Patent Law Committees

This session will address global rate-setting for standards-essential patents (SEPs) and the use of anti-suit injunctions. Speakers will discuss the role of national courts in setting global FRAND rates for standards-essential patent portfolios and in adjudicating damages for patent infringement, where the asserted patents are part of a portfolio whose FRAND value is under consideration by another national court. They will also address the related use of anti-suit and anti-interference injunctions to preclude parties from invoking the jurisdiction of other courts to address overlapping subject matter.

Artificial Intelligence in Healthcare – IP Risks and Rewards (LIVE + Virtual)
Organized by IPO’s Software Related Inventions and AI & Other Emerging Technologies Committees

Software has become increasingly intertwined with medical devices, serving to monitor, control, evaluate, extrapolate, etc. In some instances, software now forms a medical device itself (Software as a Medical Device or SaMD) to not only guide a clinician in diagnosis and/or treatment but to form its own diagnosis and/or issue its own treatment. Last year, the FDA officially codified a regulatory framework for software to be certified as a medical device. Several artificial intelligence/machine learning (AI/ML)-based technologies have since been approved by the FDA as regulated medical devices. Many more applications are under review.  This session will explore strategies for the protection of AI/ML-based SaMD according to U.S. patent practice, as well as potential conflicts between FDA and USPTO requirements.  Attendees will also learn about data protection and other legal risks that arise out of deploying predictive AI models in SaMD products, as well as techniques for safeguarding against AI privacy attacks and sensitive information leakage in AI deployments.

To 20 And Beyond! Patent Term Adjustments, Patent Term Extensions and SPCs: A U.S., European, Canadian, Brazilian and Japanese Perspective (Virtual Only)
Organized by IPO’s Pharmaceutical & Biotechnology Issues Committee

The response to the COVID-19 pandemic has once again drawn the IP world’s attention to legal provisions which extend patent term beyond the normal 20 years from filing, to compensate the patentee both for regulatory delays and for prosecution delays before the Patent Offices. For innovative pharmaceutical products, every additional day of patent term provides critical protection against early generic entry – but these provisions are under attack in many countries as pharmaceutical IP comes under scrutiny like never before. Topics will include patent term extensions / SPCs for pharmaceutical and plant protection products – compensating for regulatory delays, and patent term adjustments / minimum term from grant – compensating for Patent Office prosecution delays.

“Sufficient or Not?” A detailed look at sufficiency of disclosure for patent applications involving AI-related inventions
Organized by IPO’s AI & Other Emerging Technologies Committee

Artificial Intelligence has now found application in virtually every field of technology. Distinct from patent applications focusing on the core technology of AI itself, many patent applications now describe and claim AI-enabled systems that focus on using off-the-shelf AI tools applied to new datasets for new purposes. This raises questions about how to adequately meet the enablement and written description requirements. The operation and functionality of an AI system depend largely on the data with which it was trained. A deep neural network, for example, may have billions of parameters and as such cannot be precisely described in written form. Even the inventor/applicant may not be able to reproduce a trained AI system model exactly. Is it sufficient to describe the type of AI system used, and the type of data used to train the system? Does it matter if the training data was public or proprietary?  What information does a skilled person need, or not need, to make and use an AI-related invention without undue experimentation? These and other related questions will be addressed in this session.

Trademark/Copyright Sessions:

Recent Legislative Developments at the U.S. Copyright Office (Virtual Only)
Organized by IPO’s Copyright & Related Rights Committee

With the inclusion of the Copyright Alternative in Small-Claims Enforcement (CASE) Act as part of the Omnibus COVID-19 Relief Bill, Congress has authorized the creation of a small claims tribunal within the US Copyright Office that will adjudicate small claims infringement cases. Cases will be decided by a three-judge panel of experts in a forum where damages are capped at $15000 per claim and $30000 total. Providing an avenue for copyright infringement disputes to be heard outside of expensive federal copyright litigation creates an affordable process for independent and small creators to cost effectively enforce their rights. The Copyright Office is responsible for setting up the new tribunal and is in the process of developing the CCB (Copyright Claims Board) and has indicated that they expect the CCB to start hearing claims by Dec. 27, 2021.

Building an Effective Anti-Counterfeiting Toolbox (Virtual Only)
Organized by IPO’s Anti-Counterfeiting and Anti-Piracy Committee

This session will identify essential anti-counterfeiting tools available to help brand owners, outside counsel, and others build an effective anti-counterfeiting program. Panelists from Australia, Brazil, China, the UAE, and the US will help identify key anti-counterfeiting tools and strategies in these countries.

The Trademark Modernization Act Goes Live (Virtual Only)
Organized by IPO’s US Trademark Office Practice Committee

The Trademark Modernization Act (TMA) was signed into law at the end of 2020, with December 2021 statutory deadlines for the USPTO to implement two new ex parte post-registration proceedings. This session will provide an overview of the TMA and speakers will discuss the USPTO’s vision for the new expungement (removal) and reexamination proceedings and potential issues raised by commenters. In addition, speakers will also discuss USPTO’s experience with the updated Letter of Protest procedure and plans for flexible response periods for office actions and recommend how trademark owners can prepare for these new TMA-related changes.

The Intersection Between Branding, Social Justice & DEI (Virtual Only)
Organized by IPO’s Diversity & Inclusion and US Trademark Law Committees

This session will address the intersection of brands/branding and needed focus on equity, diversity, and inclusion. Speakers will look at what companies are doing post George Floyd and the protests across the US and globally with respect to DEI initiatives. For example, what are companies doing from an external branding, mark and advertising perspective to address DEI concerns. Have companies created new ads addressing DEI? Have they created new marks? What are companies and law firms doing internally to address DEI and how are they implementing their programs and messaging on DEI issues? The session will also focus on the roll social media plays in the branding and message strategy in DEI. How do companies react quickly in a social media age?

Challenges and Strategies for Brand Enforcement Under the Lanham Act for Unauthorized Sales of Authentic Products (LIVE + Virtual)
Organized by IPO’s Trademark Law Committee

Companies are facing an onslaught of their products being sold by third parties on e-commerce sites, many of which are outdated, damaged, or missing parts, and they are being sold at prices lower than authorized dealers can sell the products, which is causing damage to the brand and to the relationships between manufacturers and their authorized sellers. This session will explore the problem, how companies can address the problem through management of their supply chain and distribution channels, what companies can do to protect their brand through enforcement, and the current state of the law in this area.

Industrial Designs Sessions:

Anti-Counterfeiting – Enforcing Design Patents at the Border
Organized by IPO’s Industrial Designs Committee

In many countries, customs and border officials stop imports (and in some cases exports) of products that infringe industrial design rights. This can thwart knockoffs before they have a chance to confuse consumers, damage a brand, and pose safety concerns. Learn how Europe and other jurisdictions effectively police their borders for knockoffs using design rights, and get perspectives on measures being considered by the US Congress to do the same.

Update on Design Law Across Asia: What You Need to Know (Virtual Only)
Organized by IPO’s Industrial Designs and Asian Practice Committees

In the past few years, many countries in Asia have incrementally (and in some cases dramatically) updated and modernized their laws related to design rights protection. China has recently amended its laws to include protection for partial design, to make changes to its post- grant Patent Evaluation Report system, and extended patent term. Korea has expanded the Locarno classes that may be subject to only partial-substantive examination, adopted the WIPO Digital Access Service for exchange of certified copies of priority applications, and made treble damages available for willful infringement of designs. Finally, Japan has made multiple revisions to its design laws, including expanding protectible subject matter, extending terms of protection, and allowing multiple designs in a single application. Understanding these changes (and more) is crucial to developing an effective design protection strategy in these countries. This session will begin with an update from each country from local practitioners. Panelists will then compare the design law systems, considering common hypothetical situations.

Design and Copyright: Which Protects What?
Organized by IPO’s Industrial Designs Committee

Design rights can protect designs for physical and nonphysical articles. So can copyright. But what are the boundaries and differences in each type of protection? Which should you use when? When should you use both? Speakers will evaluate designs for sample physical and nonphysical articles and talk through their approaches to protecting the designs, including advantages and disadvantages between design and copyright protection in different enforcement scenarios.

Changing with the Times—How Design Laws are Changing Globally and What is Causing the Shift
Organized by IPO’s Industrial Designs Committee

Laws protecting designs have long been less-aligned globally than those protecting utility inventions. Recently, many countries have been paying attention to their design laws by seeking out public input and implementing changes. China is finally allowing partial designs to be claimed. Japan implemented provisions for improved protection of graphical user interface designs. Australia is considering adopting a general grace period. Several countries are looking at adapting design protection for new technologies such as virtual reality and augmented reality. In this session, speakers will look at major design law changes and explore trends that underlie these changes and fit them into the overall context of global design protection today. They will also compare design examination practices and outcomes in major jurisdictions and what an applicant can do to optimize their application for success in all regions.

Sponsors

Monday's IPOasis & Meeting Platform Sponsor
Attendee Welcome Kits & Virtual Networking Event
WiFi Sponsor
Virtual Fitness Challenge
Session Sponsor
IPOasis Island
Social Event Sponsor
Charging Devices Sponsor
IPOasis Island
Meeting Platform Sponsor
Lanyard Sponsor
Social Event Sponsor
IPOasis Island
IPOasis Island
Hotel Keycard Sponsor
CLE Sponsor
Pens & Badge Center Sponsor
IPOasis Island
Sponsor
Social Event Sponsor
IPOasis Island
Meeting Platform Sponsor

Media Partners

Sponsorship Opportunities

For sponsorship information or questions, contact Clara Stanfield. Please note that sponsorship opportunities are open to IPO members only. For more information on joining IPO, click here.

Committee Activities

Committees play an integral role in policy development at IPO by researching and providing analysis on current IP issues and producing recommendations for the Board of Directors. Many of IPO’s Standing IP Committees will hold virtual business meetings on Thursday, September 23 to allow for the most participation. Committee Business Meetings will not be held during the LIVE Annual Meeting in Austin. The Virtual Committee Business Meetings are open to registered attendees of the IPO LIVE+Virtual Annual Meeting. You do not have to be a member of the committee to attend.

Below is a current list of committees and their meeting date/times. Check back often as this list will be updated as meetings are confirmed.

Thursday, September 23:

9:00am-10:00am ET

  • Asian Practice Committee
  • International Trademark Law & Practice Committee

11:00am-12:00pm ET

  • Pharmaceutical & Biotechnology Issues Committee
  • Women in IP Law  Committee

1:00pm-2:00pm ET

  • Diversity & Inclusion Committee
  • International Patent Law & Trade Committee
  • Next Generation Leaders Committee
  • Trade Secrets Committee

3:00pm-4:00pm ET

  • Canadian Practice Committee
  • Copyright & Related Rights Committee
  • Damages & Injunctions Committee
  • Industrial Designs Committee
  • IP Licensing & Related Issues Committee

CLE Info

Continuing Legal Education (CLE) credit will be applied for. Additional CLE information will be provided to attendees on the IPO Annual Meeting App or in-person in Austin, TX.
For questions about CLE, please contact Susan Lusk at susan@ipo.org.

Accommodations

IPO has reserved a block of rooms at the JW Marriott, the location for the LIVE portion of IPO’s Annual Meeting (September 19-21). In order to receive the IPO group rate of $289/night + taxes for a single/double room, reservations must be made directly with the hotel by Friday, August 27, 2021, or until the room block is sold out, whichever comes first. Reference the “IPO Annual Meeting” when making your reservation. Rooms must be canceled 72 hours prior to arrival to avoid hotel cancellation fees.

Room rates are available three days before and after IPO’s Annual Meeting, pending room availability. Additional persons are $10 each per night. State & local taxes are 17.614% (as of 5/27/21), and are effective upon check-out.

JW Marriott Austin
110 E. 2nd Street | Austin, Texas 78701
Online Reservation Link (use this link to receive IPO’s group rate of $289+taxes per night)
Reservation Phone: +1-844-473-3959

Please note: IPO does not use a third-party reservation service. If you are contacted by a third-party claiming to be IPO or the JW Marriott to make a hotel reservation – do not give out your information. Please report any incidents to IPO Meetings.

IPO MEETING POLICIES

Attendee List Policy

Registration constitutes agreement by registrant for IPO to list registrant name, organization, and location on the attendee list. The attendee list is available to registrants on the first day of the meeting via the meeting platform.

Meeting Photo Waiver and Release Policy

Registration and attendance at, or participation in, IPO meetings and other activities constitutes an agreement by the registrant for IPO to use and distribute (both now and in the future), the registrant or attendee’s image or voice in photographs and audio/filming of such events and activities. These photos, audio, or film are for IPO use only and may appear on the IPO Website, newsletter, conference brochures, social media outlets, or other future IPO promotional material. This also includes photos uploaded by attendees using the IPO meeting platform or use of the public chat and forum platforms. For concerns about your image or likeness being used in this manner, please contact meetings@ipo.org.

COVID-19 Health and Safety Acknowledgement

The safety and health of our members, officers, attendees, sponsors, vendors, and staff is of the highest priority, and we are actively monitoring the guidelines and recommendations from government agencies as well as the JW Marriott and the State of Texas to ensure the safety of everyone involved. We will provide updates surrounding the IPO 2021 Annual Meeting as they become available.

Prior to purchasing a ticket to travel for and attending the IPO 2021 Annual Meeting, please ensure you have read the latest CDC guidance for prevention as well as any travel advisories or restrictions that may impact your plans.

CDC Guidance: https://www.cdc.gov/coronavirus/2019-ncov/your-health/about-covid-19.html

U.S. Department of State Travel Advisories and Restrictions: (https://travel.state.gov/content/travel/en/traveladvisories/ea/covid-19-information.html).

Please be advised that travel and attendance at in-person events involve the risk of contracting communicable diseases. By registering for the IPO 2021 Annual Meeting, you agree to comply with all safety protocols announced by IPO and the JW Marriott.

Vaccination and Face Coverings: IPO does not require attendees to be vaccinated or provide proof of vaccination in order to attend the IPO 2021 Annual Meeting. IPO and the JW Marriott do not require attendees to wear face coverings. However, it is strongly recommended that anyone who is not fully vaccinated wear a face covering and maintain physical social distancing.

Accordingly, you agree that you will not attend the IPO 2021 Annual Meeting if within fourteen days preceding the conference, you have:

  • Tested positive or presumptively positive for COVID or other communicable disease or been identified as a potential carrier of COVID or other communicable diseases, or
  • Experienced any symptoms commonly associated with COVID or other communicable diseases; or
  • Traveled to a country that is subject to a U.S. State Department Level 4 “Do Not Travel” health advisory; or
  • Been in direct contact with or the immediate vicinity of any person who is either reconfirmed or suspected of being infected with COVID or other communicable disease or who has traveled to a Prohibited Country within the last fourteen days preceding the encounter.

Please Note: The guidelines in this document are based on information currently available regarding the behavior and characteristics of the COVID-19 virus, public health information, and local or state guidelines with respect to large gatherings in any particular community. As more clarity with respect to these variables emerge, it is expected that these guidelines may need to be adjusted accordingly.

Be sure to take note of the IPO 2021 Annual Meeting Know Before You Go email prior to traveling – this will contain the latest updates and information as to what is expected on-site. The email will be sent to registered attendees approximately two weeks prior to the meeting.

Cancellation Policies

In-person Attendees: In-person attendees who cancel by 5:00 pm ET on Tuesday, August 31 will receive a partial refund of $450.00, and will still have access to the IPO Virtual Annual Meeting. Attendees are responsible for making their own hotel/travel arrangements and cancellations. All presentations and materials will be available until October 30, 2021, on the IPO Annual Meeting Virtual Platform for those no longer able to attend in person. IPO is not responsible for any travel or lodging expenses incurred due to the cancellation of the conference. If for any reason you must cancel your conference registration, please remember to cancel your housing arrangements separately. IPO is not responsible for hotel no-show fees or any travel or lodging expenses you might incur.

Virtual-only Attendees: Once registration has been processed, no refunds will be given for virtual attendee cancellations. All presentations and materials from the LIVE and virtual meetings will be available on the IPO Annual Meeting Virtual Platform until October 30, 2021.

Refunds will not be given for no-shows. Please note that fees are not transferable to another IPO meeting. Sharing materials or user’s access to the IPO Annual Meeting Platform is strictly prohibited. IPO reserves the right to cancel this event without liability, and the total amount of any and all liability of the organizers will be limited to a refund of the registration fee.

Registration and Badge Ethics 

Only persons registered for this conference (live or virtual) are admitted access to the sessions, materials, and virtual platform. Sharing of badges and/or materials is prohibited.

COVID-19 Health and Safety 

The safety and health of our members, officers, attendees, sponsors, vendors, and staff are of the highest priority, and we are actively monitoring the guidelines and recommendations from government agencies as well as the JW Marriott and the State of Texas to ensure the safety of everyone involved. We will provide updates surrounding the IPO 2021 Annual Meeting as they become available.

Prior to purchasing a ticket to travel for and attending the IPO 2021 Annual Meeting, please ensure you have read the latest CDC guidance for prevention as well as any travel advisories or restrictions that may impact your plans.

Please be advised that travel and attendance at in-person events involve the risk of contracting communicable diseases. By registering for the IPO 2021 Annual Meeting, you agree to comply with all safety protocols announced by IPO and the JW Marriott.

Vaccination and Face Coverings: IPO does not require attendees to be vaccinated or provide proof of vaccination in order to attend the IPO 2021 Annual Meeting. IPO and the JW Marriott do not require attendees to wear face coverings. However, it is strongly recommended that anyone who is not fully vaccinated wear a face covering and maintain physical social distancing.

Accordingly, you agree that you will not attend the IPO 2021 Annual Meeting if within fourteen days preceding the conference, you have:

  • Tested positive or presumptively positive for COVID or other communicable disease or been identified as a potential carrier of COVID or other communicable diseases, or
  • Experienced any symptoms commonly associated with COVID or other communicable diseases; or
  • Traveled to a country that is subject to a U.S. State Department Level 4 “Do Not Travel” health advisory; or
  • Been in direct contact with or the immediate vicinity of any person who is either reconfirmed or suspected of being infected with COVID or other communicable disease or who has traveled to a Prohibited Country within the last fourteen days preceding the encounter.

Please Note: The guidelines in this document are based on information currently available regarding the behavior and characteristics of the COVID-19 virus, public health information, and local or state guidelines with respect to large gatherings in any particular community. As more clarity with respect to these variables emerges, it is expected that these guidelines may need to be adjusted accordingly.

Be sure to take note of the IPO 2021 Annual Meeting Know Before You Go email prior to traveling – this will contain the latest updates and information as to what is expected on-site. The email will be sent to registered attendees approximately two weeks prior to the meeting.